Boneprox

Boneprox

Provides dentists with the unique opportunity of detecting patients with the risk of osteoporosis through the patented software Jaw-x.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
investor

€0.0

round
*

SEK11.0m

Grant
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
EUR2018201920202021202220232024
Revenues0000000000000000000000000000
% growth(92 %)(53 %)196 %96 %26 %139 %19 %
EBITDA0000000000000000000000000000
% EBITDA margin--(130 %)(167 %)(91 %)--
Profit0000000000000000000000000000
% profit margin(80 %)(217 %)(132 %)(168 %)(93 %)(18 %)(2 %)
EV0000000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget0000000000000000000000000000

Source: Company filings or news article

Notes (0)
More about Boneprox
Made with AI
Edit

Boneprox, established in Gothenburg, Sweden, in 2013, operates at the intersection of dental technology and healthcare, developing solutions to bridge the gap between the two fields. The company's genesis traces back to a 2005 discovery by dentist Kjell Kärrbrink, who found a method to identify osteoporosis risk using standard dental X-rays. A decade later, his grandson, Anton Kärrbrink, alongside brothers Peder and Theodor Remman, co-founded Boneprox to commercialize and build upon this initial concept.

The firm targets dental clinics, specialists, and healthcare providers, offering a suite of services through a Software-as-a-Service (SaaS) model. Its business revolves around two primary brands: Konekta and Nanok. Konekta is a telediagnostics and communication platform, functioning as a digital specialist clinic that enables dentists to quickly send digital referrals and receive second opinions from specialists in various fields, drastically reducing consultation wait times. This platform now extends to medical specialists, such as in ENT, to further integrate dental and general healthcare. Nanok is the company's artificial intelligence arm, providing sophisticated analysis of dental X-rays to assist in the early detection of oral diseases like caries and periodontitis. The AI models are trained on extensive datasets and can identify bone loss, perform cephalometric analysis, and detect caries with high precision.

Boneprox generates revenue by providing these digital tools to clinics, which improves diagnostic efficiency and patient communication. The company has secured significant funding to fuel its growth, including a $1.25 million round in March 2021 from investors like BioGaia and BackingMinds. A major milestone was achieved in 2023, when Boneprox was awarded SEK 11 million by the Research Council of Norway to lead a large-scale AI research project in dentistry called "AI-Dentify," in partnership with organizations like SINTEF.

Keywords: dental AI, telediagnostics, digital dentistry, medical technology, oral health, X-ray analysis, osteoporosis detection, Konekta, Nanok, Peder Remman, Theodor Remman, Anton Kärrbrink, dental diagnostics, healthcare software, clinical decision support, caries detection, periodontitis, cephalometric analysis, referral management, specialist network

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo